Deuterium incorporation at metabolically labile C-H bonds is an appealing strategy for improving metabolic stability and pharmacokinetic attributes in drug design campaigns. However, conventional H/D exchange methods often suffer from significant reactivity and selectivity challenges, limiting access to diverse deuterated structures. Here, we introduce a deuterium-labeled iodomethylthianthrenium reagent, readily prepared via H/D exchange with D2O, that directly converts alkenes into deuterated azetidines or cyclobutanes via a common 1,3-dielectrophilic intermediate. This method is compatible with a wide range of functional groups and is operationally simple, providing a reliable way to install deuterium at targeted positions in strained-ring scaffolds with high molecular complexity.
Building similarity graph...
Analyzing shared references across papers
Loading...
Jaebong Jang
Y. J. Han
M.-K. Kim
Synthesis
Seoul National University
Building similarity graph...
Analyzing shared references across papers
Loading...
Jang et al. (Sat,) studied this question.
www.synapsesocial.com/papers/69ca134b883daed6ee0953dd — DOI: https://doi.org/10.1055/a-2842-9696
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: